Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

TWST

Twist Bioscience Corporation

Healthcare · USD

Set alert

Price alert · TWST

All alert types
152.78 USD -20.67 -11.92%
As of Oct 30, 2026 Extended hours 151.85 -0.61%
Bid
152.78 × 2
Ask
152.95 × 2
148.00 Day range 167.27
25.45 52-week range 205.00
YTD
+381.65%
1 year
+390.15%
Open
161.39
Prev close
173.45
Mkt cap
10.13B
Vol
3.40M
Avg vol
2.30M
EPS
-2.23
P/E
0.00
Div yield
0.00%
More statistics
Low
148.00
High
167.27
Forward P/E
-381.95
Beta
2.19
Short ratio
3.22
Inst. own
116.96%
Dividend
0.00
Ex-div date
Earnings
Nov 12, 2026
50-d avg
152.78
200-d avg
88.45
1y target
168.25

5D chart

Chart tools
Interval
1m5m15m30m
TWST five-day price chart136.2146.8157.4167.9178.5Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

27.59 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E -21.6×
FY 2016: -6.0×FY 2017: -4.4×FY 2018: -5.2×FY 2019: -6.1×FY 2020: -21.3×FY 2021: -34.0×FY 2022: -8.7×FY 2023: -5.6×FY 2024: -12.5×FY 2025: -21.6×
FY 2016 5y median -12.5× FY 2025
P/S 4.5×
FY 2016: 116×FY 2017: 24.4×FY 2018: 14.7×FY 2019: 12.1×FY 2020: 33.0×FY 2021: 39.0×FY 2022: 9.3×FY 2023: 4.7×FY 2024: 8.4×FY 2025: 4.5×
FY 2016 5y median 8.4× FY 2025
P/B 3.6×
FY 2016: -3.4×FY 2017: -2.0×FY 2018: -1.8×FY 2019: 4.3×FY 2020: 8.9×FY 2021: 8.9×FY 2022: 2.4×FY 2023: 1.8×FY 2024: 5.5×FY 2025: 3.6×
FY 2016 5y median 3.6× FY 2025
P/FCF -22.3×
FY 2016: -5.9×FY 2017: -4.5×FY 2018: -5.3×FY 2019: -6.4×FY 2020: -19.6×FY 2021: -37.1×FY 2022: -8.4×FY 2023: -6.8×FY 2024: -37.9×FY 2025: -22.3×
FY 2016 5y median -22.3× FY 2025
EV/EBITDA -31.4×
FY 2016: -6.3×FY 2017: -4.5×FY 2018: -4.7×FY 2019: -6.2×FY 2020: -22.1×FY 2021: -33.1×FY 2022: -7.6×FY 2023: -5.5×FY 2024: -14.0×FY 2025: -31.4×
FY 2016 5y median -14.0× FY 2025
EV/Sales 4.3×
FY 2016: 108×FY 2017: 22.4×FY 2018: 11.9×FY 2019: 11.3×FY 2020: 32.4×FY 2021: 36.0×FY 2022: 7.9×FY 2023: 3.9×FY 2024: 7.9×FY 2025: 4.3×
FY 2016 5y median 7.9× FY 2025
FCF Yield -4.5%
FY 2016: -17.0%FY 2017: -22.0%FY 2018: -18.8%FY 2019: -15.7%FY 2020: -5.1%FY 2021: -2.7%FY 2022: -11.9%FY 2023: -14.8%FY 2024: -2.6%FY 2025: -4.5%
FY 2016 5y median -4.5% FY 2025

Profitability

Gross Margin 50.7%
FY 2016: -315.2%FY 2017: -123.1%FY 2018: -26.6%FY 2019: 12.8%FY 2020: 31.8%FY 2021: 39.1%FY 2022: 41.4%FY 2023: 36.6%FY 2024: 42.6%FY 2025: 50.7%
FY 2016 5y median 41.4% FY 2025
Operating Margin -36.2%
FY 2016: -1924.0%FY 2017: -543.2%FY 2018: -277.5%FY 2019: -200.1%FY 2020: -155.5%FY 2021: -115.4%FY 2022: -115.3%FY 2023: -88.6%FY 2024: -70.6%FY 2025: -36.2%
FY 2016 5y median -88.6% FY 2025
Net Margin -20.6%
FY 2016: -1943.1%FY 2017: -550.8%FY 2018: -280.2%FY 2019: -198.0%FY 2020: -155.3%FY 2021: -114.9%FY 2022: -107.0%FY 2023: -83.5%FY 2024: -66.7%FY 2025: -20.6%
FY 2016 5y median -83.5% FY 2025
ROE -16.4%
FY 2016: 57.5%FY 2017: 44.5%FY 2018: 35.4%FY 2019: -70.8%FY 2020: -41.6%FY 2021: -26.2%FY 2022: -27.6%FY 2023: -32.8%FY 2024: -44.2%FY 2025: -16.4%
FY 2016 5y median -27.6% FY 2025
ROIC -24.1%
FY 2016: -63.1%FY 2017: -76.8%FY 2018: -70.7%FY 2019: -68.0%FY 2020: -37.6%FY 2021: -23.2%FY 2022: -25.3%FY 2023: -30.2%FY 2024: -39.6%FY 2025: -24.1%
FY 2016 5y median -25.3% FY 2025
ROA -12.1%
FY 2016: -57.7%FY 2017: -69.2%FY 2018: -61.5%FY 2019: -57.6%FY 2020: -35.1%FY 2021: -21.7%FY 2022: -22.7%FY 2023: -26.4%FY 2024: -34.0%FY 2025: -12.1%
FY 2016 5y median -22.7% FY 2025

Growth (YoY)

Revenue 20.3%
FY 2016: 0.0%FY 2017: 374.5%FY 2018: 136.2%FY 2019: 113.9%FY 2020: 65.7%FY 2021: 46.9%FY 2022: 53.8%FY 2023: 20.4%FY 2024: 27.7%FY 2025: 20.3%
FY 2016 FY 2025
Operating Income 38.3%
FY 2016: 0.0%FY 2017: -34.0%FY 2018: -20.7%FY 2019: -54.3%FY 2020: -28.7%FY 2021: -9.0%FY 2022: -53.7%FY 2023: 7.5%FY 2024: -1.7%FY 2025: 38.3%
FY 2016 FY 2025
EPS (diluted) 63.9%
FY 2016: 0.0%FY 2017: -34.5%FY 2018: 15.2%FY 2019: -46.3%FY 2020: 8.9%FY 2021: 11.8%FY 2022: -28.3%FY 2023: 10.9%FY 2024: 0.0%FY 2025: 63.9%
FY 2016 FY 2025
Free Cash Flow -9.3%
FY 2016: 0.0%FY 2017: -29.2%FY 2018: -20.7%FY 2019: -47.0%FY 2020: -48.1%FY 2021: 8.4%FY 2022: -62.4%FY 2023: 24.7%FY 2024: 59.4%FY 2025: -9.3%
FY 2016 FY 2025

Financial Health

Current Ratio 3.6×
FY 2016: 6.8×FY 2017: 7.2×FY 2018: 5.2×FY 2019: 5.3×FY 2020: 9.3×FY 2021: 8.7×FY 2022: 6.6×FY 2023: 5.8×FY 2024: 4.9×FY 2025: 3.6×
FY 2016 5y median 5.8× FY 2025
Quick Ratio 3.3×
FY 2016: 6.7×FY 2017: 7.0×FY 2018: 4.8×FY 2019: 5.0×FY 2020: 9.0×FY 2021: 8.2×FY 2022: 6.1×FY 2023: 5.3×FY 2024: 4.5×FY 2025: 3.3×
FY 2016 5y median 5.3× FY 2025
Debt / Equity 0.3×
FY 2016: -0.1×FY 2017: -0.1×FY 2018: -0.0×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.2×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA 0.9×
FY 2016: 0.4×FY 2017: 0.4×FY 2018: 1.1×FY 2019: 0.4×FY 2020: 0.4×FY 2021: 2.8×FY 2022: 1.3×FY 2023: 1.1×FY 2024: 0.8×FY 2025: 0.9×
FY 2016 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2016: -58.5×FY 2017: -64.6×FY 2018: -53.7×FY 2019: -84.1×FY 2020: -178×FY 2021: -416×FY 2022: -2935×FY 2023: -43432×FY 2024: -7615×FY 2025: 0.0×
FY 2016 5y median -2935× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30